141 related articles for article (PubMed ID: 15450938)
1. Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model.
Martirosyan AR; Rahim-Bata R; Freeman AB; Clarke CD; Howard RL; Strobl JS
Biochem Pharmacol; 2004 Nov; 68(9):1729-38. PubMed ID: 15450938
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
3. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
4. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells.
Jori FP; Melone MA; Napolitano MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
Cell Death Differ; 2005 Jan; 12(1):65-77. PubMed ID: 15459751
[TBL] [Abstract][Full Text] [Related]
5. Potent in vivo anti-breast cancer activity of IN-2001, a novel inhibitor of histone deacetylase, in MMTV/c-Neu mice.
Joung KE; Min KN; An JY; Kim DK; Kong G; Sheen YY
Cancer Res; 2006 May; 66(10):5394-402. PubMed ID: 16707467
[TBL] [Abstract][Full Text] [Related]
6. Molecular correlates of the action of bis(ethyl)polyamines in breast cancer cell growth inhibition and apoptosis.
Faaland CA; Thomas TJ; Balabhadrapathruni S; Langer T; Mian S; Shirahata A; Gallo MA; Thomas T
Biochem Cell Biol; 2000; 78(4):415-26. PubMed ID: 11012080
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells.
Fortunati N; Bertino S; Costantino L; Bosco O; Vercellinatto I; Catalano MG; Boccuzzi G
Cancer Lett; 2008 Feb; 259(2):156-64. PubMed ID: 18006146
[TBL] [Abstract][Full Text] [Related]
8. The spot 14 protein inhibits growth and induces differentiation and cell death of human MCF-7 breast cancer cells.
Sanchez-Rodriguez J; Kaninda-Tshilumbu JP; Santos A; Perez-Castillo A
Biochem J; 2005 Aug; 390(Pt 1):57-65. PubMed ID: 15819613
[TBL] [Abstract][Full Text] [Related]
9. C-(2-chloroquinoline-3-yl)-N-phenyl nitrone: new synthetic antioxidant inhibits proliferation and induces apoptosis of breast carcinoma MCF-7 cells.
Ramadan M; Gamal-Eldeen AM; Abdel-Aziz M; Abuo-Rahma Gel-D; Abdel-Nabi H; Nagib AH
Arch Pharm (Weinheim); 2006 May; 339(5):242-9. PubMed ID: 16586432
[TBL] [Abstract][Full Text] [Related]
10. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.
Poma P; Notarbartolo M; Labbozzetta M; Maurici A; Carina V; Alaimo A; Rizzi M; Simoni D; D'Alessandro N
Int J Mol Med; 2007 Sep; 20(3):329-35. PubMed ID: 17671737
[TBL] [Abstract][Full Text] [Related]
11. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
12. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells.
Morley KL; Ferguson PJ; Koropatnick J
Cancer Lett; 2007 Jun; 251(1):168-78. PubMed ID: 17197076
[TBL] [Abstract][Full Text] [Related]
13. Apple phytochemical extracts inhibit proliferation of estrogen-dependent and estrogen-independent human breast cancer cells through cell cycle modulation.
Sun J; Liu RH
J Agric Food Chem; 2008 Dec; 56(24):11661-7. PubMed ID: 19053381
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of a series of novel synthetic sulfonate esters on human breast cancer cell line MCF-7.
Cyr L; Langler RF; Crandall I; Lavigne C
Anticancer Res; 2007; 27(3B):1437-48. PubMed ID: 17595759
[TBL] [Abstract][Full Text] [Related]
15. The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines.
Savickiene J; Borutinskaite VV; Treigyte G; Magnusson KE; Navakauskiene R
Eur J Pharmacol; 2006 Nov; 549(1-3):9-18. PubMed ID: 16978604
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes.
Zhang B; Laribee RN; Klemsz MJ; Roman A
Virology; 2004 Nov; 329(1):189-98. PubMed ID: 15476886
[TBL] [Abstract][Full Text] [Related]
17. Novel ceramide analogs as potential chemotherapeutic agents in breast cancer.
Struckhoff AP; Bittman R; Burow ME; Clejan S; Elliott S; Hammond T; Tang Y; Beckman BS
J Pharmacol Exp Ther; 2004 May; 309(2):523-32. PubMed ID: 14742741
[TBL] [Abstract][Full Text] [Related]
18. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
20. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
